JP2013504554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013504554A5 JP2013504554A5 JP2012528455A JP2012528455A JP2013504554A5 JP 2013504554 A5 JP2013504554 A5 JP 2013504554A5 JP 2012528455 A JP2012528455 A JP 2012528455A JP 2012528455 A JP2012528455 A JP 2012528455A JP 2013504554 A5 JP2013504554 A5 JP 2013504554A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- guaifenesin
- group
- maleate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- 230000028327 secretion Effects 0.000 claims 7
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 claims 6
- 229960002146 guaifenesin Drugs 0.000 claims 6
- 210000003097 mucus Anatomy 0.000 claims 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 4
- 239000000739 antihistaminic agent Substances 0.000 claims 4
- 239000003434 antitussive agent Substances 0.000 claims 4
- 229940124584 antitussives Drugs 0.000 claims 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims 4
- 239000000850 decongestant Substances 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 claims 2
- PMGQWSIVQFOFOQ-BDUVBVHRSA-N (e)-but-2-enedioic acid;(2r)-2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCC[C@@H]1CCOC(C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PMGQWSIVQFOFOQ-BDUVBVHRSA-N 0.000 claims 2
- WFXURHIXPXVPGM-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 WFXURHIXPXVPGM-UHFFFAOYSA-N 0.000 claims 2
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 claims 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical group OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 2
- KBAUFVUYFNWQFM-UHFFFAOYSA-N Doxylamine succinate Chemical compound OC(=O)CCC(O)=O.C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 KBAUFVUYFNWQFM-UHFFFAOYSA-N 0.000 claims 2
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 claims 2
- 102000015728 Mucins Human genes 0.000 claims 2
- 108010063954 Mucins Proteins 0.000 claims 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 2
- 230000000954 anitussive effect Effects 0.000 claims 2
- 230000001387 anti-histamine Effects 0.000 claims 2
- 229940125715 antihistaminic agent Drugs 0.000 claims 2
- 229960003108 brompheniramine maleate Drugs 0.000 claims 2
- SRGKFVAASLQVBO-BTJKTKAUSA-N brompheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 SRGKFVAASLQVBO-BTJKTKAUSA-N 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 229940046978 chlorpheniramine maleate Drugs 0.000 claims 2
- 229940001468 citrate Drugs 0.000 claims 2
- 229960002689 clemastine fumarate Drugs 0.000 claims 2
- 229940124581 decongestants Drugs 0.000 claims 2
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 claims 2
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 229960005008 doxylamine succinate Drugs 0.000 claims 2
- 229960002179 ephedrine Drugs 0.000 claims 2
- 229960003592 fexofenadine Drugs 0.000 claims 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- 229960003956 phenindamine tartrate Drugs 0.000 claims 2
- 229960003733 phenylephrine hydrochloride Drugs 0.000 claims 2
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 claims 2
- 229960003910 promethazine Drugs 0.000 claims 2
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 claims 2
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 238000013268 sustained release Methods 0.000 claims 2
- 239000012730 sustained-release form Substances 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/558,517 US20110065744A1 (en) | 2009-09-12 | 2009-09-12 | Method Of Inhibiting Mucin Secretion |
| US12/558,517 | 2009-09-12 | ||
| GB1002039.4 | 2010-02-09 | ||
| GBGB1002039.4A GB201002039D0 (en) | 2010-02-09 | 2010-02-09 | Method of inhibiting mucin secretion |
| PCT/GB2010/051525 WO2011030163A1 (en) | 2009-09-12 | 2010-09-13 | Use of guaifenesin for inhibiting mucin secretion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013504554A JP2013504554A (ja) | 2013-02-07 |
| JP2013504554A5 true JP2013504554A5 (enExample) | 2013-10-31 |
Family
ID=42941393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528455A Pending JP2013504554A (ja) | 2009-09-12 | 2010-09-13 | ムチン分泌を抑制するためのグアイフェネシンの使用 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2475360A1 (enExample) |
| JP (1) | JP2013504554A (enExample) |
| KR (1) | KR20120068889A (enExample) |
| CN (1) | CN102596189A (enExample) |
| AU (1) | AU2010294008B2 (enExample) |
| BR (1) | BR112012005517A2 (enExample) |
| CA (1) | CA2773611A1 (enExample) |
| MX (1) | MX2012003042A (enExample) |
| MY (1) | MY161187A (enExample) |
| RU (1) | RU2012114323A (enExample) |
| WO (1) | WO2011030163A1 (enExample) |
| ZA (1) | ZA201201822B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1206995A1 (en) * | 2012-04-06 | 2016-01-22 | The Uab Research Foundation | Methods for increasing cftr activity |
| KR102211605B1 (ko) * | 2018-02-26 | 2021-02-04 | 대한민국 | 개구리 배아를 이용한 기도 뮤신 분비 억제제의 스크리닝 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA963590B (en) * | 1995-05-10 | 1996-11-19 | Adcock Ingram Ltd | Pharmaceutical composition |
| US6846799B1 (en) * | 1998-08-18 | 2005-01-25 | The Regents Of The University Of California | Preventing airway mucus production by administration of EGF-R antagonists |
| US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| EP1471872A2 (en) * | 2002-02-04 | 2004-11-03 | Pharmacia Corporation | Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof |
| CN1835942A (zh) * | 2003-06-19 | 2006-09-20 | 金纳莱公司 | 粘蛋白合成抑制剂 |
| US20050095288A1 (en) * | 2003-11-03 | 2005-05-05 | Andrx Labs, Llc | Decongestant and expectorant tablets |
| US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| US20080014261A1 (en) * | 2006-07-12 | 2008-01-17 | Giordano John A | Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| US20090202633A1 (en) * | 2008-01-03 | 2009-08-13 | Siva Ramakrishna Velaga | Extended release formulations of guaifenesin |
-
2010
- 2010-09-13 BR BR112012005517A patent/BR112012005517A2/pt not_active Application Discontinuation
- 2010-09-13 MY MYPI2012001112A patent/MY161187A/en unknown
- 2010-09-13 CA CA2773611A patent/CA2773611A1/en not_active Abandoned
- 2010-09-13 AU AU2010294008A patent/AU2010294008B2/en not_active Ceased
- 2010-09-13 CN CN2010800492171A patent/CN102596189A/zh active Pending
- 2010-09-13 WO PCT/GB2010/051525 patent/WO2011030163A1/en not_active Ceased
- 2010-09-13 MX MX2012003042A patent/MX2012003042A/es unknown
- 2010-09-13 RU RU2012114323/15A patent/RU2012114323A/ru unknown
- 2010-09-13 EP EP10757117A patent/EP2475360A1/en not_active Ceased
- 2010-09-13 KR KR1020127007996A patent/KR20120068889A/ko not_active Withdrawn
- 2010-09-13 JP JP2012528455A patent/JP2013504554A/ja active Pending
-
2012
- 2012-03-13 ZA ZA2012/01822A patent/ZA201201822B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6226916B2 (ja) | 医薬組成物 | |
| RU2485942C2 (ru) | Бупропиона гидробромид и его терапевтические применения | |
| ES2333308T3 (es) | Composiciones que contienen ambas antihistaminas sedantes y no sedantes. | |
| US20120121729A1 (en) | Antitussive compositions comprising memantine | |
| TWI302460B (en) | Pharmaceutical compositions and use thereof | |
| CN106456550A (zh) | 避免乙醇剂量倾泻的多颗粒 | |
| JP2009538920A5 (enExample) | ||
| RU2008151950A (ru) | Фармацевтическая лекарственная форма пролонгированного высвобождения, содержащая фенилэфрин | |
| RU2013135509A (ru) | Твердая единица дозирования в пленочной оболочке, содержащей мед | |
| AU2007254826B2 (en) | Pharmaceutical compositions for sustained release of phenyephrine | |
| WO2020086673A1 (en) | Ketamine oral transmucosal delivery system | |
| JP2010513229A (ja) | 軽減された肝毒性を含む最小限に抑制された副作用を有するアセトアミノフェン組成物 | |
| US20200368216A1 (en) | Treatment of sunburn using analgesics and antihistamines | |
| US20080311196A1 (en) | All Day Rhinitic Condition Treatment Regimen | |
| JP2013513652A5 (enExample) | ||
| JP2013504554A5 (enExample) | ||
| CA2825690A1 (en) | Pharmaceutical formulation | |
| JP2013513651A5 (enExample) | ||
| RU2012114323A (ru) | Применение гвайфенезина для ингибирования секреции муцина | |
| JP2020511455A5 (enExample) | ||
| TW200838525A (en) | Methods for treating nasal congestion | |
| TW200838524A (en) | Methods for treating nasal congestion in hepatically impaired patients | |
| JP2007513095A5 (enExample) | ||
| ZA202405485B (en) | Solid oral dosage forms of rabeprazole | |
| UA77796U (uk) | Композиція для лікування алергічних станів |